- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07654205
Smartphone-based Intervention for Young Adults With ADHD
Training Inhibitory Control Using Personalized Strategies (TIPS): A Randomized Controlled Feasibility Trial of a Smartphone-Based Intervention for Alcohol Use in Young Adults With ADHD
The primary goal of this clinical trial is to test if a smartphone-based intervention is feasible & acceptable among young adults with ADHD who also engage in risky drinking behaviors. A secondary aim is to test preliminary intervention efficacy. The main questions it aims to answer are:
Is the smartphone intervention feasible & acceptable for participants (e.g., are they responding regularly, is there a low level of burden reported)?
Does the smartphone intervention improve symptom awareness, inhibitory control, and problematic alcohol use?
Participants will:
Attend a virtual baseline visit to assess ADHD, alcohol use, and other life experiences.
Complete either the TIPS smartphone intervention or a control smartphone protocol over the course of 31-days, starting the first Friday after the baseline visit.
Attend a virtual follow-up visit, where many of the same questions from the baseline visit will be asked again.
Aperçu de l'étude
Statut
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Traci Kennedy, PhD
- Numéro de téléphone: 4122466087
- E-mail: kennedytm2@upmc.edu
Sauvegarde des contacts de l'étude
- Nom: Aiden Williard, B.S.
- Numéro de téléphone: 4127324911
- E-mail: williarda@upmc.edu
Lieux d'étude
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, États-Unis, 15213
- Recrutement
- University of Pittsburgh
-
Contact:
- Traci Kennedy, PhD
- Numéro de téléphone: 4122466087
- E-mail: kennedytm2@upmc.edu
-
Contact:
- Aiden Williard, B.S.
- Numéro de téléphone: 4127324911
- E-mail: williarda@upmc.edu
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- Age 18-25
- Current diagnosis of Attention Deficit/Hyperactivity Disorder-Combined Type according to the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM 5)
- Drinks at least 4 (for females) / 5 (for males) alcoholic drinks in a single drinking session at least once per week
- Owns a smartphone
- Reads and understands English
Exclusion Criteria:
- Currently in high school
- Actively in treatment for Alcohol Use Disorder
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Intervention Arm
Participants in this arm will be randomly assigned to the Experimental condition of the smartphone portion.
|
Participants will rate their ADHD symptoms and impairment 4 times daily.
Feedback on changes in ADHD symptoms will be provided visually via a graph at each prompt.
They will also be texted suggestions following each survey to try behavioral strategies intended to help with their inhibitory control ADHD symptoms and related problems, with a particular focus on alcohol use and problems).
|
|
Comparateur factice: Control Arm
Participants in this arm will be randomly assigned to the Control condition of the smartphone portion.
|
Participants will receive 4 prompts per day in the same time windows as participants in the intervention group.
However, participants in the control conditions will not be given the 3 TIPS intervention components (symptom monitoring, symptom feedback, and tailored strategy suggestions) and instead will report about their drinking behaviors.
They will also answer several "neutral" questionnaires that have been designed by the study team to keep intervention prompt length similar between groups.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Average Completion Rate
Délai: Enrollment to Completion of 31-Day Intervention Period
|
Completion rate will be defined as number of surveys completed out of the 124 that will be sent during the 31-day smartphone intervention period.
4 surveys will be sent every day.
An average completion rate of 80% in the intervention group would indicate good feasibility.
|
Enrollment to Completion of 31-Day Intervention Period
|
|
Average mHealth App Usability Questionnaire (MAUQ) Rating
Délai: Within 1 month of intervention completion
|
The usability of the smartphone intervention will be assessed using the 18-item mHealth App Usability Questionnaire (MAUQ), rated from 1-disagree to 7-agree, with an average of at least 5 indicating good usability.
|
Within 1 month of intervention completion
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in past-month average alcohol quantity
Délai: Enrollment to Completion of 31-Day Intervention Period,
|
A change in past-month average alcohol quantity from pre- to post-intervention, as measured by the 31-day timeline followback interview.
|
Enrollment to Completion of 31-Day Intervention Period,
|
|
Change in number of past-month binge-drinking episodes
Délai: Enrollment to Completion of 31-Day Intervention Period
|
A change in number of past-month binge-drinking episodes from pre- to post- intervention, as measured by the timeline followback interview. Binge-drinking is defined as drinking 4 or more drinks in assigned female at birth participants, or 5 or more drinks in assigned male at birth participants within a 2-hour period. |
Enrollment to Completion of 31-Day Intervention Period
|
|
Change in number of past-month alcohol problems reported on the Young Adult Alcohol Consequence Questionnaire
Délai: Enrollment to Completion of 31-Day Intervention Period
|
Participants will complete the 23-item Young Adult Alcohol Consequence Questionnaire at baseline (pre-intervention) and follow-up (post-intervention).
For each item, participants will indicate whether the item is something they have experienced in the past month.
|
Enrollment to Completion of 31-Day Intervention Period
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in inhibitory control
Délai: Enrollment to Completion of 31-Day Intervention Period
|
Participants and collateral reported will complete the 8-item Inhibit subscale of the Behavior Rating Inventory of Executive Function Adult Version (BRIEF-A) at baseline (pre-intervention) and post-intervention follow-up.
|
Enrollment to Completion of 31-Day Intervention Period
|
|
Change in awareness
Délai: Enrollment to Completion of 31-Day Intervention Period
|
A change in awareness of inhibitory control from pre- to post-intervention, as measured by the 15 item Mindful Attention Awareness Scale (MAAS)
|
Enrollment to Completion of 31-Day Intervention Period
|
|
Change in objectively measured inhibitory control
Délai: Enrollment to Completion of 31-Day Intervention Period
|
A change in objectively measured inhibitory control based on mobile CuedGoNoGo responses (rate of commission errors, i.e., when the participant tapped their screen when they weren't supposed to)
|
Enrollment to Completion of 31-Day Intervention Period
|
|
Change in awareness of errors on mobile CuedGoNoGo task
Délai: Enrollment to Completion of 31-Day Intervention Period
|
A change in awareness of errors made on the mobile CuedGoNoGo task (i.e., accuracy of participant's guess of how many commission errors they made), assessed immediately after completion of the task.
|
Enrollment to Completion of 31-Day Intervention Period
|
|
Change in ADHD symptom severity
Délai: Enrollment to Completion of 31-Day Intervention Period
|
A change from baseline to post-intervention follow-up in ADHD symptom severity, as measured by clinician-administered and collateral informant-reported ADHD Rating Scale scores.
|
Enrollment to Completion of 31-Day Intervention Period
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Traci Kennedy, PhD., University of Pittsburgh
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- STUDY25080182
- K23AA029133 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
All collected IPD will be shared with the National Institute on Alcohol Abuse and Alcoholism Data Archive (NIAAADA).
Analytic code may be shared on an open science platform at the time of publication of results.
Délai de partage IPD
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- ANALYTIC_CODE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .